Citations for
Epigenetic modifications induced by RGC-32 in colon cancer.
Vlaicu SI, Tegla CA, Cudrici CD, Fosbrink M, Nguyen V, Azimzadeh P, Rus V, Chen H, Mircea PA, Shamsuddin A, Rus H.
Exp Mol Pathol 88(1):67-76. Epub 2009 Oct 31. 2010
Response gene to complement 32, a novel hypoxia-regulated angiogenic inhibitor.
An X, Jin Y, Guo H, Foo SY, Cully BL, Wu J, Zeng H, Rosenzweig A, Li J.
Circulation 120(7):617-27. Epub 2009 Aug 3. 2009
Response gene to complement 32 expression is induced by the luteinizing hormone (LH) surge and regulated by LH-induced mediators in the rodent ovary.
Park ES, Choi S, Muse KN, Curry TE Jr, Jo M.
Endocrinology 149(6):3025-36. Epub 2008 Feb 28. 2008
RGC32, a novel p53-inducible gene, is located on centrosomes during mitosis and results in G2/M arrest.
Saigusa K, Imoto I, Tanikawa C, Aoyagi M, Ohno K, Nakamura Y, Inazawa J.
Oncogene 26(8):1110-21. Epub 2006 Dec 4. 2007
Overexpression of RGC-32 in colon cancer and other tumors.
Fosbrink M, Cudrici C, Niculescu F, Badea TC, David S, Shamsuddin A, Shin ML, Rus H.
Exp Mol Pathol 78(2):116-22. Epub 2005 Jan 5. 2005
6CDK1, RGC32
RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase.
Badea T, Niculescu F, Soane L, Fosbrink M, Sorana H, Rus V, Shin ML, RusH.
J Biol Chem 277(1):502-8. Epub 2001 Oct 30. 2002